Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
3101
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.42M | ﹤0.01% |
760,816
+63,195
| +9% | +$300K |
|
3102
Century Therapeutics
IPSC
$361M
| $3.42M | ﹤0.01% |
215,324
+10,633
| +5% | +$200K |
|
3103
Aldeyra Therapeutics
ALDX
$93.5M
| $3.41M | ﹤0.01% |
852,760
-49,157
| -5% | -$375K |
|
|
HGEN
3104
DELISTED
HUMANIGEN, INC.
HGEN
| $3.41M | ﹤0.01% |
916,157
+417,276
| +84% | +$2.44M |
|
3105
Shore Bancshares
SHBI
$822M
| $3.41M | ﹤0.01% |
163,415
+58,045
| +55% | +$1.12M |
|
|
ATHX
3106
DELISTED
Athersys, Inc. Common Stock
ATHX
| $3.41M | ﹤0.01% |
150,944
+3,222
| +2% | +$92.4K |
|
3107
Sight Sciences
SGHT
$288M
| $3.39M | ﹤0.01% |
193,022
+12,796
| +7% | +$281K |
|
3108
Ceco Environmental
CECO
$4.09B
| $3.38M | ﹤0.01% |
542,980
+8,329
| +2% | +$55.2K |
|
3109
Fortress Biotech
FBIO
$92.7M
| $3.37M | ﹤0.01% |
89,840
-905
| -1% | -$40.4K |
|
|
NVMI
3110
Nova
NVMI
$12.9B
| $3.37M | ﹤0.01% |
22,974
+32
| +0.1% | +$3.87K |
|
3111
Freedom Holding
FRHC
$9.85B
| $3.36M | ﹤0.01% |
48,451
+1,490
| +3% | +$100K |
|
|
ADN
3112
DELISTED
Advent Technologies
ADN
| $3.36M | ﹤0.01% |
15,969
-2,817
| -15% | -$703K |
|
|
LENZ
3113
LENZ Therapeutics
LENZ
$167M
| $3.35M | ﹤0.01% |
38,454
+1,686
| +5% | +$140K |
|
|
PSTX
3114
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.34M | ﹤0.01% |
490,599
+113,850
| +30% | +$776K |
|
|
TBHC
3115
DELISTED
The Brand House Collective
TBHC
| $3.33M | ﹤0.01% |
223,366
-5,513
| -2% | -$114K |
|
|
STR
3116
DELISTED
Sitio Royalties
STR
| $3.33M | ﹤0.01% |
171,157
-5,313
| -3% | -$113K |
|
|
CASA
3117
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $3.33M | ﹤0.01% |
588,006
-5,804
| -1% | -$33.6K |
|
3118
Matrix Service
MTRX
$336M
| $3.33M | ﹤0.01% |
443,141
+1,275
| +0.3% | +$12K |
|
|
SHCO
3119
DELISTED
Soho House & Co
SHCO
| $3.33M | ﹤0.01% |
260,588
+23,386
| +10% | +$280K |
|
3120
INNOVATE Corp
VATE
$99.3M
| $3.33M | ﹤0.01% |
89,968
-2,125
| -2% | -$84.5K |
|
|
CSLT
3121
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.3M | ﹤0.01% |
2,145,882
+135,794
| +7% | +$224K |
|
|
NUVL
3122
DELISTED
Nuvalent
NUVL
| $3.3M | ﹤0.01% |
173,404
+9,569
| +6% | +$213K |
|
|
NAGE
3123
Niagen Bioscience
NAGE
$250M
| $3.29M | ﹤0.01% |
881,268
+17,054
| +2% | +$92.1K |
|
3124
ClearPoint Neuro
CLPT
$393M
| $3.29M | ﹤0.01% |
293,492
+1,656
| +0.6% | +$24.8K |
|
|
AKUS
3125
DELISTED
Akouos Inc
AKUS
| $3.29M | ﹤0.01% |
386,774
+12,766
| +3% | +$115K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.